Frontiers in Public Health (Nov 2022)

Corrigendum: Cost-utility analysis of lurasidone for the first-line treatment of schizophrenia in China

Jia Liu,
Jia Liu,
Lidan Cao,
Lidan Cao,
Jing Wu,
Jing Wu

Affiliations

Jia Liu: School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China
Jia Liu: Center for Social Science Survey and Data, Tianjin University, Tianjin, China
Lidan Cao: School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China
Lidan Cao: Center for Social Science Survey and Data, Tianjin University, Tianjin, China
Jing Wu: School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China
Jing Wu: Center for Social Science Survey and Data, Tianjin University, Tianjin, China

DOI: https://doi.org/10.3389/fpubh.2022.1059495
Journal volume & issue: Vol. 10

Abstract

No abstracts available.

Published in Frontiers in Public Health

ISSN: 2296-2565 (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Medicine: Public aspects of medicine
Website: https://www.frontiersin.org/journals/public-health

About the journal